S

Steven Cohen

Point72 Asset Management, L.P.

Multi-strategie

Founder of Point72 Asset Management following the closure of SAC Capital, Steven Cohen runs a multi-strategy fund combining discretionary, quantitative, and venture investing.

Portfolio
$78.1B
Equity positions
24
Top 10 concentration
0.3%
Weighted yield
-
Dividend coverage
0.0%

Portfolio as of March 31, 2026

Company Value %
Loading…

Quarterly moves

Q4 2025 → Q1 2026

New buys

Amount invested · % of portfolio

7
Positions added to

Amount bought · (±%) · % of portfolio

12
Positions trimmed

Amount sold · (±%) · % of portfolio

13

Portfolio value over time

Top 10 holdings evolution as of March 31, 2026

Share of portfolio (%) since inception, top 10 as of the selected quarter.

Sector breakdown

Based on holdings matched to a stock referenced on the site.

Options exposure

Call options $116M (16)
Put options $59M (10)

Dividend aristocrats held

Stocks with at least 25 consecutive years of dividend growth.

No matching holding among stocks referenced on the site.

Frequently asked questions

What are Steven Cohen's top holdings?

As of March 31, 2026, the top three holdings of Point72 Asset Management, L.P. are ABIVAX SA, ACADIA PHARMACEUTICALS INC, ADMA BIOLOGICS INC.

How many positions does Steven Cohen hold?

Point72 Asset Management, L.P. reports 24 equity positions worth $78.1B as of March 31, 2026.

Does Steven Cohen invest in dividend stocks?

The dividend exposure of this portfolio cannot be assessed yet.

Data sourced from 13F filings submitted to the SEC, published with roughly 45 days of lag. A 13F only covers long positions in U.S.-traded securities: it excludes short sales, non-U.S. holdings and cash. Provided for informational purposes only and does not constitute investment advice.